Kevin Baszis, M.D.

Profile picture
Associate Professor of Pediatrics, Rheumatology and Immunology
Rheumatology and Immunology

phone: (314) 454-6124


  • BLA, University of Missouri-Kansas City School of Medicine2003
  • MD, Graduated with Distinction, University of Missouri-Kansas City2004


  • Pediatric Resident, St. Louis Children's Hospital2004 - 2007
  • Pediatric Chief Resident, St. Louis Children's Hospital2007 - 2008
  • Pediatric Rheumatology Fellow, Washington University School of Medicine2008 - 2011
  • Education Skills Training, WUSM2018 - 2019

Licensure and Board Certification

  • 2007 - PresMO, State Board of Registration for the Healing Arts
  • 2008 - PresAmerican Board of Pediatrics, General Pediatrics
  • 2013 - PresAmerican Board of Pediatrics, Pediatric Rheumatology
  • 2018 - PresRheumatology Musculoskeletal Ultrasound (RhMSUS) Certification; American College of Rheumatology
  • 2019 - PresIL, Department of Financial and Professional Registration
  • 2021 - PresAR, Arkansas State Medical Board

Honors and Awards

  • Alpha Omega Alpha member2003 - Pres
  • March 2015 Lecturer of the Month, WUSM/SLCH Residency Didactics2015
  • August 2015 Lecturer of the Month, WUSM/SLCH Residency Didactics2015

Recent Publications view all (21)

Publication Co-Authors

  1. Favorable outcomes with reduced steroid use in juvenile dermatomyositis. Pediatr Rheumatol Online J. 2021;19(1):127. PMCID:PMC8369654  PMID:34404425 
  2. Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis. J Rheumatol. 2021;48(4):567-574. PMCID:PMC7736056  PMID:32541073 
  3. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019;78(12):1722-1731. PMID:31562126 
  4. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J. 2018;16(1):84. PMCID:PMC6311016  PMID:30594206 
  5. Rare presentation of an atrial myxoma in an adolescent patient: a case report and literature review. BMC Pediatr. 2018;18(1):373. PMCID:PMC6263045  PMID:30486815 
  6. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA). Pediatr Rheumatol Online J. 2017;15(1):71. PMCID:PMC5609060  PMID:28934971 
  7. Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis. J Rheumatol. 2017. PMID:28916545 
  8. Four Cases of Anti-PM/Scl Antibody-positive Juvenile Overlap Syndrome with Features of Myositis and Systemic Sclerosis. J Rheumatol. 2016;43(9):1768-9. PMID:27587018 
  9. Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases. Pediatr Rheumatol Online J. 2016;14(1):37. PMCID:PMC4918135  PMID:27333803 
  10. Mesenteric vasculitis in children with systemic lupus erythematosus. Clin Rheumatol. 2015. doi:10.1007/s10067-015-2892-3  PMID:25687984 
  11. Pediatric vasculitis: recognizing multisystemic manifestations at body imaging. Radiographics. 2015;35(3):849-65. doi:10.1148/rg.2015140076  PMID:25969938 
  12. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34(5):594-9. doi:10.1007/s10875-014-0038-z  PMCID:PMC4047151  PMID:24760111 
  13. Scurvy revealed by difficulty walking: three cases in young children. J Clin Rheumatol. 2014;20(4):224-8. doi:10.1097/RHU.0000000000000101  PMID:24847751 
  14. The heart and pediatric rheumatology. Rheum Dis Clin North Am. 2014;40(1):61-85. doi:10.1016/j.rdc.2013.10.008  PMID:24268010 
  15. The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia. Lupus. 2012;21(14):1575-81. doi:10.1177/0961203312464803  PMID:23161578 
  16. Recurrent cardiac tamponade in a child with newly diagnosed systemic-onset juvenile idiopathic arthritis. J Clin Rheumatol. 2012;18(6):304-6. doi:10.1097/RHU.0b013e3182685857  PMID:22955481 
  17. Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol. 2012;39(8):1687-97. doi:10.3899/jrheum.111352  PMID:22589257 
  18. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012;64(8):1175-85. doi:10.1002/acr.21687  PMID:22505322 
  19. Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol. 2012;39(5):1088-94. doi:10.3899/jrheum.111030  PMID:22337238 
  20. Recurrent parotitis as a presentation of primary pediatric Sjögren syndrome. Pediatrics. 2012;129(1):e179-82. doi:10.1542/peds.2011-0716  PMID:22184654 
  21. Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum. 2011;63(10):3163-8. doi:10.1002/art.30502  PMID:21702011 
Last updated: 10/14/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130